Blood Cells, Molecules, and Diseases
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 41.7% | 0.852 | Q2 | 79.3% |
| 2024 | 1.7 | Q3 | 34.3% | 0.633 | Q2 | 70.3% |
| 2023 | 2.1 | Q3 | 52.8% | 0.584 | Q2 | 70.1% |
| 2022 | 2.3 | Q4 | 49.0% | 0.718 | Q2 | 77.5% |
| 2021 | 2.4 | Q3 | 49.0% | 0.720 | Q2 | 78.3% |
| 2020 | — | — | 0.844 | Q2 | 81.2% | |
| 2019 | — | — | 0.740 | Q2 | 78.4% | |
| 2018 | — | — | 0.696 | Q2 | 74.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1079-9796
ISSN
1096-0961
country
UScoverage
1995-2026